The fibronectin isoform containing the ED-B oncofetal domain: A marker of angiogenesis

P. Castellani, g. Viale, A. Dorcaratto, G. Nicolo, J. Kaczarek, G. Querze, L. Zardi

Research output: Contribution to journalArticle

Abstract

Different fibronectin (FN) isoforms are generated by the alternative splicing of 3 regions (ED-A, ED-B and IIICS) of the primary transcript. The FN isoform containing the ED-B sequence, a complete type-III-homology repeat, while having extremely restricted distribution in normal adult tissues, reveals high expression in fetal and tumor tissues. Using the monoclonal antibody (MAb) BC-1, specific for the FN isoform containing the ED-B sequence (B+ FN), we demonstrate here, using immunohistochemical techniques, that while this FN isoform is undetectable in mature vessels, it is highly expressed during angiogenesis both in neoplastic and in normal tissues, as in the case of the functional layer of endometrium during the proliferative phase. B+ FN is thus a marker for the formation of new vessels, and the BC-1 MAb may be a useful reagent for evaluating the level of the angiogenetic process in different neoplasms.

Original languageEnglish
Pages (from-to)612-618
Number of pages7
JournalInternational Journal of Cancer
Volume59
Issue number5
DOIs
Publication statusPublished - 1994

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'The fibronectin isoform containing the ED-B oncofetal domain: A marker of angiogenesis'. Together they form a unique fingerprint.

  • Cite this